| Reprogramming of human somatic cells to pluripotency with defined factors IH Park, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, ... Nature 451 (7175), 141-146, 2007 | 3722 | 2007 |
| Disease-specific induced pluripotent stem cells IH Park, N Arora, H Huo, N Maherali, T Ahfeldt, A Shimamura, MW Lensch, ... cell 134 (5), 877-886, 2008 | 2783 | 2008 |
| Connexin mutations in X-linked Charcot-Marie-Tooth disease J Bergoffen, SS Scherer, S Wang, MO Scott, LJ Bone, DL Paul, K Chen, ... Science 262 (5142), 2039-2042, 1993 | 1379 | 1993 |
| DNA deletion associated with hereditary neuropathy with liability to pressure palsies PF Chance, MK Alderson, KA Leppig, MW Lensch, N Matsunami, B Smith, ... Cell 72 (1), 143-151, 1993 | 945 | 1993 |
| Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells K Kim, R Zhao, A Doi, K Ng, J Unternaehrer, P Cahan, H Hongguang, ... Nature biotechnology 29 (12), 1117-1119, 2011 | 729 | 2011 |
| LIF/STAT3 signaling fails to maintain self‐renewal of human embryonic stem cells L Dahéron, SL Opitz, H Zaehres, WM Lensch, PW Andrews, ... Stem cells 22 (5), 770-778, 2004 | 624 | 2004 |
| Biomechanical forces promote embryonic haematopoiesis L Adamo, O Naveiras, PL Wenzel, S McKinney-Freeman, PJ Mack, ... Nature 459 (7250), 1131-1135, 2009 | 586 | 2009 |
| Hallmarks of pluripotency A De Los Angeles, F Ferrari, R Xi, Y Fujiwara, N Benvenisty, H Deng, ... Nature 525 (7570), 469-478, 2015 | 473 | 2015 |
| Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1 KH Baek, A Zaslavsky, RC Lynch, C Britt, Y Okada, RJ Siarey, MW Lensch, ... Nature 459 (7250), 1126-1130, 2009 | 408 | 2009 |
| Reprogramming of T cells from human peripheral blood YH Loh, O Hartung, H Li, C Guo, JM Sahalie, PD Manos, A Urbach, ... Cell stem cell 7 (1), 15, 2010 | 401 | 2010 |
| Peripheral myelin protein–22 gene maps in the duplication in chromosome 17p11. 2 associated with Charcot–Marie–Tooth 1A N Matsunami, B Smith, L Ballard, MW Lensch, M Robertson, H Albertsen, ... Nature genetics 1 (3), 176-179, 1992 | 372 | 1992 |
| Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17 PF Chance, N Abbas, MW Lensch, L Pentao, BB Roa, PI Patel, JR Lupski Human Molecular Genetics 3 (2), 223-228, 1994 | 371 | 1994 |
| High‐efficiency RNA interference in human embryonic stem cells H Zaehres, MW Lensch, L Daheron, SA Stewart, J Itskovitz‐Eldor, ... Stem Cells 23 (3), 299-305, 2005 | 367 | 2005 |
| Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera MW Lensch, TM Schlaeger, LI Zon, GQ Daley Cell Stem Cell 1 (3), 253-258, 2007 | 173 | 2007 |
| Severe vincristine neuropathy in charcot‐marie‐tooth disease type 1A WD Graf, PF Chance, MW Lensch, LJ Eng, HP Lipe, TD Bird Cancer 77 (7), 1356-1362, 1996 | 171 | 1996 |
| Broader implications of defining standards for the pluripotency of iPSCs. GQ Daley, MW Lensch, R Jaenisch, A Meissner, K Plath, S Yamanaka Cell Stem Cell 4 (3), 200, 2009 | 148 | 2009 |
| Investigating monogenic and complex diseases with pluripotent stem cells H Zhu, MW Lensch, P Cahan, GQ Daley Nature Reviews Genetics 12 (4), 266-275, 2011 | 121 | 2011 |
| Trisomy 17p associated with Charcot‐Marie‐Tooth neuropathy type 1A phenotype Evidence for gene dosage as a mechanism in CMT1A PF Chance, TD Bird, N Matsunami, MW Lensch, AR Brothman, ... Neurology 42 (12), 2295-2295, 1992 | 112 | 1992 |
| The terminology of teratocarcinomas and teratomas MW Lensch, TA Ince Nature biotechnology 25 (11), 1211-1211, 2007 | 111* | 2007 |
| Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage A Tulpule, MW Lensch, JD Miller, K Austin, A D'Andrea, TM Schlaeger, ... Blood 115 (17), 3453-3462, 2010 | 101 | 2010 |
